Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 2 - Antenatal care

    • By Clare Tower, Clinical Lecture, Maternal and Fetal Health Research Centre, St Mary's Hospital, University of Manchester, Manchester, UK
  • Alexander Heazell, University of Manchester, John Clift
  • Book:
    Obstetrics for Anaesthetists
    Published online:
    21 August 2009
    Print publication:
    06 March 2008, pp 11-21

  • Summary

    The National Institute for Health and Clinical Excellence (NICE) produced guidelines for antenatal care provision. The first antenatal visit or 'booking visit' is essential to identifying potential risk factors. Most women in the UK attend for booking in the late first trimester or early second trimester. Those attending in the third trimester are likely to have risk factors placing them in a higher risk category. Blood pressure (BP) should be measured at booking. Pregnant women are offered screening for rubella, syphilis, hepatitis B and HIV. Screening policies for fetal abnormality vary from region to region. The National Screening Committee suggested that women with a risk of 1:250 or more should be offered additional testing in the form of amniocentesis or chorionic villus sampling. Serum alphafetoprotein (AFP) testing in the second trimester is offered as a screening test for neural tube defects.